CD8A and hepatocellular carcinoma: The anti-platelet effect of aspirin prevented HCC and improved survival in a mouse model of chronic hepatitis B by reducing the number of intrahepatic HBV-specific CD8+ T cells and HBV-nonspecific inflammatory cells and the severity of liver fibrosis [34].